The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOL SMARTTOUCH® SF catheters in the treatment of drug refractory symptomatic persistent atrial fibrillation (PsAF) during standard electrophysiology mapping and RF ablation procedures.
Principal Investigator: J. Brian DeVille, MD
Locations: Baylor Scott & White The Heart Hospital – Plano
Sponsor: Biosense Webster
IRB Number: 016-181
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: N/A
Penni Dolton, RN469.814.4735Penni.Dolton@BSWHealth.org
Heath Shirkey, RN469.814.4185Heath.Shirkey@BSWHealth.org
Prospective Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH SF Catheter Evaluation for Treating Symptomatic Persistent AF (PRECEPT)
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.